Contraception at age 35 years and older

Clinical Obstetrics and Gynecology

Volumn 41, Issue 4, 1998, Pages 951-957

  Westhoff, Carolyn ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE;

ADULT; CARDIOVASCULAR RISK; CONTRACEPTION; FEMALE; FEMALE FERTILITY; HORMONAL CONTRACEPTION; HORMONE BLOOD LEVEL; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MENOPAUSE; ORAL CONTRACEPTION; OVARY FUNCTION; OVULATION; PREGNANCY; REVIEW; UTERINE TUBE LIGATION;

ADULT; AGE FACTORS; AMERICAS; CLINIC ACTIVITIES; CONTRACEPTION; CONTRACEPTIVE METHODS; CONTRACEPTIVE USAGE--WOMEN; COUNSELING--WOMEN; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; FAMILY PLANNING; MIDDLE AGED--WOMEN; NORTH AMERICA; NORTHERN AMERICA; ORAL CONTRACEPTIVES; ORGANIZATION AND ADMINISTRATION; POPULATION; POPULATION CHARACTERISTICS; PROGRAM ACTIVITIES; PROGRAMS; UNITED STATES;

ADOLESCENT; ADULT; CLIMACTERIC; CONTRACEPTION; FERTILITY; HUMANS; MATERNAL AGE; MIDDLE AGED; POPULATION GROWTH; PREGNANCY, HIGH-RISK; STERILIZATION, TUBAL; UNITED STATES;

EID: 0032462484     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199812000-00021     Document Type: Review

References (26)

1. U.S. Bureau of the Census, Statistical Abstract of the United States: 1996 (116th edition.) Washington, DC, 1996.
2. Abma J, Chandra A, Mosher W, Peterson L, Piccinino L. Fertility, family planning, and women's health: New data from the 1995 National Survey of Family Growth. National Center for Health Statistics. Vital Health Stat. 1997;23.
3. Menken J, Trussell J, Larsen U. Age and infertility. Science. 1986;233:1389.
4. Tietze C, Guttmacher AF, Rubin S. Time required for conception in 1727 planned pregnancies. Fertil Steril. 1950;1:338.
5. Howe G, Westhoff C, Vessey M, Yeates D. Effects of age, cigarette smoking, and other factors on fertility: findings in a large prospective study. Br Med J. 1985; 290:1697.
6. Federation CECOS, Schwartz D, Mayeux MJ. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermatic husbands. N Engl J Med. 1982;306: 404.
7. Westhoff C. The epidemiology of infertility. In Reproductive and Perinatal Epidemiology. M. Kiely, ed. Boca Raton CRC Press 1991.
8. Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussel J. The risk of pregnancy after tubal sterilization: Findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol. 1996; 174:1161-1170.
9. Royal College of General Practitioners. Oral contraceptive study: mortality among oral contraceptive users. Lancet. 1977;2: 727.
10. Croft P, Hannaford PC. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study. Br Med J. 1989;298:165-168.
11. Lewis MA, Heinemann LAJ, Spitzer WO, MacRae KD, Bruppacher R. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women: results from the transnational study on oral contraceptives and the health of young women. Contraception. 1997;56:129-140.
12. Sidney S, Petitti DB, Quesenberry Jr CP, Klatsky AL, Ziel HK, Wolf S. Myocardial infarction in users of low-dose oral contraceptives. Obstet Gynecol. 1996;88:939-944.
13. Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK. Stroke in users of low-dose contraceptives. N Engl J Med. 1996;335:8-15.
14. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet. 1995; 346:1575-1582.
15. Suissa S, Biais L, Spitzer WO, Cusson J, Lewis M, Heinemann L. First-time use of newer oral contraceptives and the risk of venous thromboembolism. Contraception. 1997;56:141-146.
16. WHO. Oral contraceptives and neoplasia. WHO Technical Report 1992;Series 817: 8-12.
17. DeCherney A. Bone-sparing properties of oral contraceptives. Am J Obstet Gynecol. 1996; 174:15-20.
18. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas. 1992;14:103-115.
19. Ross RK, Pike MC, Vessey MP, et al. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br J Obstet Gynaecol. 1986;96:359-362.
20. Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust N Z J Obstet Gynaecol. 1991;31:66-70.
21. Gebbie AE, Glasier A, Sweeting V. Incidence of ovulation in perimenopausal women before and during hormone replacement therapy. Contraception. 1995;52:221-222.
22. Sherman BM, West JH, Korenman SG. The menopausal transition: analysis of LH, FSH, estradiol and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab. 1976;42: 629-636.
23. Castracane VD, Gimpel T, Goldzieher JW. When is it safe to switch from oral contraceptives to hormone replacement therapy? Contraception. 1995;52:371-376.
24. Creinin MD. Laboratory criteria for menopause in women using oral contraceptives. Fertil Steril. 1996;66:101-104.
25. Westhoff C. The IUD in evolution. Obstet Gynecol Surv 1996;51(suppl):S20-S24.
26. Flynn AM. Symptothermal and hormonal markers of potential fertility in climacteric women. Am J Obstet Gynecol. 1991;165: 1987-1989.